Pages that link to "Q36478273"

The following pages link to Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance (Q36478273):

Displaying 37 items.

• Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria (Q24614989) (← links)
• Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda (Q28125904) (← links)
• Advances in understanding the genetic basis of antimalarial drug resistance (Q28471642) (← links)
• A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast (Q28488932) (← links)
• Extreme mutation bias and high AT content in Plasmodium falciparum (Q33558392) (← links)
• In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda (Q33676088) (← links)
• Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations (Q33723453) (← links)
• Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso (Q33826359) (← links)
• Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana (Q33870057) (← links)
• Pharmacogenetics of antimalarial drugs: effect on metabolism and transport (Q34020238) (← links)
• Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda (Q34529355) (← links)
• Plasmodium drug targets outside the genetic control of the parasite (Q34678568) (← links)
• Modeling the effects of relapse in the transmission dynamics of malaria parasites. (Q35237540) (← links)
• Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites (Q35270425) (← links)
• Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay (Q35368698) (← links)
• Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future (Q36012531) (← links)
• Multiplex PCR and oligonucleotide microarray for detection of single-nucleotide polymorphisms associated with Plasmodium falciparum drug resistance (Q36747592) (← links)
• Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy (Q36828711) (← links)
• Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development (Q36832446) (← links)
• Drug-resistant malaria - an insight (Q36933785) (← links)
• Transporter-mediated uptake into cellular compartments (Q36985076) (← links)
• Preparation of bicyclic 1,2,4-trioxanes from gamma,delta-unsaturated ketones (Q37132632) (← links)
• Synthesis and antimalarial activities of cyclen 4-aminoquinoline analogs (Q37144874) (← links)
• A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria (Q37190605) (← links)
• Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration (Q37402952) (← links)
• Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso (Q37527013) (← links)
• Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy (Q37538729) (← links)
• Malaria and iron: history and review (Q37599856) (← links)
• ABC transporters involved in drug resistance in human parasites. (Q37941754) (← links)
• Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China (Q39208596) (← links)
• In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes (Q39224800) (← links)
• Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin (Q41944932) (← links)
• Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277). (Q42018084) (← links)
• Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis (Q42112110) (← links)
• Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine (Q46120029) (← links)
• In vivo and in vitro antimalarial effect and toxicological evaluation of the chloroquine analogue PQUI08001/06 (Q56341107) (← links)
• Physical Characterization of Halofantrine-Encapsulated Fat Nanoemulsions (Q91291338) (← links)